Department of Pharmacy, West China Hospital, Sichuan University, Chengdu, China.
Int J Clin Pract. 2021 Aug;75(8):e14348. doi: 10.1111/ijcp.14348. Epub 2021 May 21.
Multimorbidity and polypharmacy in older adults always increase the prevalence of potentially inappropriate medications (PIMs) and affect the quality of life of older adults. Currently, the data of PIMs on Chinese geriatric outpatients based on Beers criteria 2015 and 2019 have not been studied. The purposes of this study were aimed to investigate the prevalence of PIMs prescription and the most frequent PIMs amongst outpatients according to the two criteria and to explore related risk factors for PIMs.
The cross-sectional retrospective study was conducted amongst geriatric outpatients in Chengdu in tertiary hospitals from January 2018 to December 2018. The Beers criteria 2015 and 2019 were used to assess PIMs in geriatric outpatients. Univariate analysis and multivariate logistic regression analysis were adopted to determine the factors that may affect the prevalence of PIMs.
A total of 12 005 patient prescriptions were enrolled. The prevalence of PIMs in the Beers criteria 2015 and 2019 was 30.98% and 34.39%, respectively. Benzodiazepines, diuretics and selective serotonin reuptake inhibitors (SSRIs) were the most frequent PIMs used according to both criteria. Logistic regression analysis showed that patients with female, advanced age, polypharmacy and sleep disorder were the most important factors associated with PIMs use.
The results showed a high prevalence of PIMs amongst geriatric outpatients in China. The Beers criteria 2019 had a higher detection rate of PIMs, and it was more sensitive to assess the Chinese geriatric population.
老年人的多病共存和多种药物治疗会增加潜在不适当药物(PIMs)的发生率,并影响老年人的生活质量。目前,尚未研究基于 2015 年和 2019 年 Beers 标准的中国老年门诊患者 PIMs 数据。本研究旨在调查根据这两个标准,门诊患者中 PIMs 处方的流行率和最常见的 PIMs,并探讨与 PIMs 相关的危险因素。
这是一项在 2018 年 1 月至 12 月期间在三级医院的成都老年门诊患者中进行的横断面回顾性研究。使用 2015 年和 2019 年 Beers 标准评估老年门诊患者的 PIMs。采用单因素分析和多因素逻辑回归分析确定可能影响 PIMs 流行率的因素。
共纳入 12005 份患者处方。根据 2015 年和 2019 年 Beers 标准,PIMs 的流行率分别为 30.98%和 34.39%。苯二氮䓬类药物、利尿剂和选择性 5-羟色胺再摄取抑制剂(SSRIs)是根据这两个标准使用的最常见的 PIMs。逻辑回归分析显示,女性、年龄较大、多种药物治疗和睡眠障碍的患者是与 PIMs 使用最相关的重要因素。
结果表明,中国老年门诊患者中 PIMs 的流行率较高。2019 年 Beers 标准对 PIMs 的检出率更高,对评估中国老年人群更敏感。